{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:42:34Z","timestamp":1792510954172,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:00:00Z","timestamp":1750464000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007658","name":"Baxter Healthcare Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007658","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Critical Care"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jcrc.2025.155151","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T23:55:52Z","timestamp":1751932552000},"page":"155151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["An economic model for different anticoagulation strategies in continuous renal replacement therapy"],"prefix":"10.1016","volume":"90","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8314-5090","authenticated-orcid":false,"given":"Olivier","family":"Ethgen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Zarbock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2651-0821","authenticated-orcid":false,"given":"Jorge","family":"Echeverri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Harenski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashita","family":"Tolwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcrc.2025.155151_bb0005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40560-017-0251-y","article-title":"Practical approach to detection and management of acute kidney injury in critically ill patient","volume":"5","author":"Mohsenin","year":"2017","journal-title":"J Intensive Care"},{"key":"10.1016\/j.jcrc.2025.155151_bb0010","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s13054-016-1353-y","article-title":"Acute kidney injury: short-term and long-term effects","volume":"20","author":"Doyle","year":"2016","journal-title":"Crit Care"},{"key":"10.1016\/j.jcrc.2025.155151_bb0015","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/s12882-017-0729-9","article-title":"Hospital acquired acute kidney injury is associated with increased mortality but not increased readmission rates in a UK acute hospital","volume":"18","author":"Jurawan","year":"2017","journal-title":"BMC Nephrol"},{"issue":"1","key":"10.1016\/j.jcrc.2025.155151_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12882-019-1645-y","article-title":"Burden of acute kidney injury and 90-day mortality in critically ill patients","volume":"21","author":"Wiersema","year":"2019","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.jcrc.2025.155151_bb0025","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12882-023-03196-0","article-title":"Use of novel structural features to identify urinary biomarkers during acute kidney injury that predict progression to chronic kidney disease","volume":"24","author":"Charlton","year":"2023","journal-title":"BMC Nephrol"},{"issue":"12","key":"10.1016\/j.jcrc.2025.155151_bb0030","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/s00134-023-07169-7","article-title":"Epidemiology of surgery associated acute kidney injury (EPIS-AKI): a prospective international observational multi-center clinical study","volume":"49","author":"Zarbock","year":"2023","journal-title":"Intensive Care Med"},{"issue":"6","key":"10.1016\/j.jcrc.2025.155151_bb0035","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/sdi.12967","article-title":"Continuous renal replacement therapy principles","volume":"34","author":"Claure-Del Granado","year":"2021","journal-title":"Semin Dial"},{"issue":"3","key":"10.1016\/j.jcrc.2025.155151_bb0040","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.chest.2018.09.004","article-title":"Continuous renal replacement therapy: who, when, why, and how","volume":"155","author":"Tandukar","year":"2019","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.jcrc.2025.155151_bb0045","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s00134-023-07211-8","article-title":"Initiation of continuous renal replacement therapy versus intermittent hemodialysis in critically ill patients with severe acute kidney injury: a secondary analysis of STARRT-AKI trial","volume":"49","author":"Wald","year":"2023","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2025.155151_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2024.154764","article-title":"Initial renal replacement therapy (RRT) modality associates with 90-day postdischarge RRT dependence in critically ill AKI survivors","volume":"82","author":"Koyner","year":"2024","journal-title":"J Crit Care"},{"issue":"5","key":"10.1016\/j.jcrc.2025.155151_bb0055","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s12630-019-01306-x","article-title":"Renal replacement therapy: a practical update","volume":"66","author":"Alvarez","year":"2019","journal-title":"Can J Anaesth"},{"issue":"2","key":"10.1016\/j.jcrc.2025.155151_bb0060","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1525-139X.2008.00545.x","article-title":"Anticoagulation for continuous renal replacement therapy","volume":"22","author":"Tolwani","year":"2009","journal-title":"Semin Dial"},{"issue":"26","key":"10.1016\/j.jcrc.2025.155151_bb0065","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1056\/NEJMct1206045","article-title":"Continuous renal-replacement therapy for acute kidney injury","volume":"367","author":"Tolwani","year":"2012","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jcrc.2025.155151_bb0070","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/sdi.12959","article-title":"Anticoagulation strategies in continuous renal replacement therapy","volume":"34","author":"Legrand","year":"2021","journal-title":"Semin Dial"},{"issue":"2","key":"10.1016\/j.jcrc.2025.155151_bb0075","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/CNQ.0000000000000397","article-title":"Review of anticoagulation in continuous renal replacement therapy","volume":"45","author":"Roe","year":"2022","journal-title":"Crit Care Nurs Q"},{"key":"10.1016\/j.jcrc.2025.155151_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD012467.pub2","article-title":"Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy","author":"Tsujimoto","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"16","key":"10.1016\/j.jcrc.2025.155151_bb0085","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1001\/jama.2020.18618","article-title":"Effect of regional citrate anticoagulation vs systemic heparin anticoagulation during continuous kidney replacement therapy on dialysis filter life span and mortality among critically ill patients with acute kidney injury: a randomized clinical trial","volume":"324","author":"Zarbock","year":"2020","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.jcrc.2025.155151_bb0090","doi-asserted-by":"crossref","first-page":"c179","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guidelines for acute kidney injury","volume":"120","author":"Khwaja","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.jcrc.2025.155151_bb0095","first-page":"1","article-title":"KDIGO clinical practice guideline for acute kidney injury","volume":"2","author":"KDIGO AKI Work Group","year":"2012","journal-title":"Kidney Int Suppl"},{"issue":"2","key":"10.1016\/j.jcrc.2025.155151_bb0100","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000342378","article-title":"Advances in continuous renal replacement therapy: citrate anticoagulation update","volume":"34","author":"Tolwani","year":"2012","journal-title":"Blood Purif"},{"issue":"13","key":"10.1016\/j.jcrc.2025.155151_bb0105","article-title":"Heparin versus citrate anticoagulation for continuous renal replacement therapy in intensive care: the RRAM observational study","volume":"26","author":"Gould","year":"2022","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jcrc.2025.155151_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2022.154218","article-title":"Regional citrate anticoagulation versus systemic heparin anticoagulation for continuous kidney replacement therapy in intensive care","volume":"74","author":"Doidge","year":"2023","journal-title":"J Crit Care"},{"key":"10.1016\/j.jcrc.2025.155151_bb0115","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1007\/s00134-015-4099-0","article-title":"Citrate versus heparin anticoagulation for continuous renal replacement therapy: an updated meta-analysis of RCTs","volume":"41","author":"Bai","year":"2015","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2025.155151_bb0120","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13054-016-1299-0","article-title":"Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials","volume":"20","author":"Liu","year":"2016","journal-title":"Crit Care"},{"key":"10.1016\/j.jcrc.2025.155151_bb0125","first-page":"1","article-title":"Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis of randomized controlled trials","author":"Li","year":"2022","journal-title":"Ther Apher Dial"},{"issue":"1","key":"10.1016\/j.jcrc.2025.155151_bb0130","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s13054-023-04519-1","article-title":"Anticoagulation options for continuous renal replacement therapy in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials","volume":"27","author":"Zhou","year":"2023","journal-title":"Crit Care"},{"issue":"8","key":"10.1016\/j.jcrc.2025.155151_bb0135","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1097\/01.CCM.0000227656.31911.2E","article-title":"Long-term survival, quality of life, and quality-adjusted life-years among critically ill elderly patients","volume":"34","author":"Kaarlola","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2025.155151_bb0140","article-title":"Economic analysis of renal replacement therapy modality in acute kidney injury patients with fluid overload","volume":"5;5(6):e0921","author":"Ethgen","year":"2023","journal-title":"Crit Care Explor"},{"key":"10.1016\/j.jcrc.2025.155151_bb0145","author":"Center for Medicare and Mediaid Services (CMS)"},{"key":"10.1016\/j.jcrc.2025.155151_bb0150","author":"US Bureau of Labor Statistics (BLS)"},{"key":"10.1016\/j.jcrc.2025.155151_bb0155","author":"US Bureau of Labor Statistics (BLS)"},{"key":"10.1016\/j.jcrc.2025.155151_bb0160","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jval.2019.03.003","article-title":"A new method to determine the optimal willingness to pay in cost-effectiveness analysis","volume":"22","author":"Phelps","year":"2019","journal-title":"Value Heath"},{"key":"10.1016\/j.jcrc.2025.155151_bb0165","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7326\/M20-1392","article-title":"A health opportunity cost threshold for cost-effectiveness analysis in the United States","volume":"174","author":"Vanness","year":"2021","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.jcrc.2025.155151_bb0170","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1186\/cc1071","article-title":"The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients","volume":"5","author":"Cook","year":"2001","journal-title":"Crit Care"},{"issue":"2","key":"10.1016\/j.jcrc.2025.155151_bb0175","doi-asserted-by":"crossref","first-page":"2290932","DOI":"10.1080\/0886022X.2023.2290932","article-title":"Anticoagulation practices for continuous renal replacement therapy: a survey of physicians from the United States","volume":"45","author":"Boldt","year":"2023","journal-title":"Ren Fail"},{"key":"10.1016\/j.jcrc.2025.155151_bb0180","author":"ClinicalTrials.gov, US National Library of Medicine"},{"key":"10.1016\/j.jcrc.2025.155151_bb0185","author":"ClinicalTrials.gov, US National Library of Medicine"}],"container-title":["Journal of Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944125001388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944125001388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:57:29Z","timestamp":1792508249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883944125001388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":37,"alternative-id":["S0883944125001388"],"URL":"https:\/\/doi.org\/10.1016\/j.jcrc.2025.155151","relation":{},"ISSN":["0883-9441"],"issn-type":[{"value":"0883-9441","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An economic model for different anticoagulation strategies in continuous renal replacement therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Critical Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcrc.2025.155151","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"155151"}}